• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Immunomedics Inc. (IMMU)

    -NasdaqGM
    2.20 Up 0.38(20.88%) Feb 5, 4:00PM EST
    |After Hours : 2.22 Up 0.02 (0.91%) Feb 5, 7:53PM EST
    Prev Close:1.82
    Open:2.06
    Bid:2.19 x 2100
    Ask:2.28 x 800
    1y Target Est:2.00
    Beta:1.34517
    Earnings Date:May 4 - May 9 (Est.)
    Day's Range:2.06 - 2.49
    52wk Range:1.50 - 5.05
    Volume:9,877,464
    Avg Vol (3m):757,254
    Market Cap:208.43M
    P/E (ttm):N/A
    EPS (ttm):-0.54
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMMU

    Comparison

    Symbol% ChgMkt Cap
    IMMUUp 20.88%208.43M
    GSKDown 0.54%98.64B
    BIIBDown 3.44%57.70B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):34.62
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-16) :-0.31
    Quarterly EPS Est (Mar-16) :-0.13
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Immunomedics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback